Recent Finacing
Recent Raise
Neogene Therapeutics develops personalized engineered T cell therapies targeting tumor neoantigens, using a platform that sequences biopsies to identify TCR genes, synthesizes and screens them and engineers T cells.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Neogene Therapeutics.
